Dr. Kris Ghosh - Escondido OB-GYN Medical Center Inc

Escondido Ob-Gyn
Medical Group, Inc.
488 E. Valley Pkwy
Escondido, CA 92025

Hours of Operation:
Mon-Thu 9:00 - 4:30
Fri 9:00 - 2:00




	KRIS GHOSH, M.D.
	Obstetrician and Gynecologist

EDUCATION

1984 –1988 B.S. (Honors) Biology	Indiana University
1984 –1988 B.A. Mathematics	Indiana University
1988 –1993 M.D.	Indiana University School of Medicine
2006 - 2008 M.B.A.	UCLA Anderson School of Management

POSTDOCTORAL TRAINING

Internships and Residencies
1993 - 1994	Internship in Obstetrics & Gynecology, UCLA Medical Center, Los Angeles, California
1994 - 1997	Resident in Obstetrics & Gynecology, UCLA Medical Center, Los Angeles, California
1995 - 1995	Felix Rutledge Fellow, Department of Gynecologic Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas
1997 - 2000	Fellow in Gynecologic Oncology, University of Minnesota Medical Center, Minneapolis, Minnesota

Licensure and Certification
1994	National Board of Medical Examiners (428529)
1995	Medical Board of California (G080421)
1996	Indiana State Board of Medicine (01043872)
1997	The American Board of Obstetrics and Gynecology Passed - 12/7/2001
1997 - 2000	Minnesota Medical Board (39981)
2000	The American Board of Obstetrics and Gynecology Speciality Qualification of Gynecologic Oncology (Eligible- passed written exam) Oral Examination - 4/2004
2000 - 2002	Massachusetts Board of Registration (204632)

Academic Appointments
1986 - 1987	Graduate Instructor of Calculus, Mathematics Department, Indiana University
1997 - 2000	Clinical Fellow in Gynecologic Oncology, University of Minnesota School of Medicine
1997 - 2000	Clinical Instructor, Department of Obstetrics and Gynecology, University of Minnesota School of Medicine
2000 - 2001	Instructor, Department of Obstetrics & Gynecology, Harvard Medical School
2001 - 2002	Assistant Professor, Department of Obstetrics & Gynecology, Harvard Medical School

Hospital Appointments
1997 - 1999	Consulting Staff, Olive - View-UCLA Medical Center, Sylmar, CA
1997 - 2000	Attending Staff, Fairview-University Medical Center, Minn., MN
1997 - 2000	Courtesy Staff, Methodist Hospital, St.Louis Park, MN
1997 - 2000	Courtesy Staff, Hennepin County Medical Center, Minneapolis, MN
1997 - 2000	Courtesy Staff, North Memorial Hospital, Robbinsdale, MN
1997 - 2000	Courtesy Staff, Abbott Northwestern Hospital, Minneapolis, MN
2000 - 2002	Active Staff, Beth Israel Deaconess Medical Center, Boston, MA
2000 - 2002	Consulting Staff, Mount Auburn Hospital, Cambridge, MA
2002	Active Staff, Scripps Clinic, La Jolla, CA
2002	Active Staff, Sharp Health Care, San Diego, CA
2002	Active Staff, Palomar/Pomerado Hospitals, San Diego, CA

Other Professional Positions and major Visiting Appointments
1997 - 2000	Co-Principal Investigator, Gynecologic Oncology Group
2000 - 2002	Prinicipal Investigator, Gynecologic Oncology Group
1999 - 2001	Consultant, Iatrosoft Corporation
2001	Consultant, Johnson & Johnson, Ethicon Surgical Division
2001	Consultant and Speaker, Cytyc Corp.
2001	Consultant and Speaker, Glaxo Smithklein Pharmaceuticals
2002	Consultant and Speaker, Aventis Pharmaceuticals

Hospital and Health Care Organization Service Responsibilities
1997 - 1999	Clinical Effectiveness Committee, Fairview-University Medical Center, Minneapolis, MN

Major Administrative Responsibilities
1991 - 1993	Co-Founder, Vice-President of The Gatch Surgical Society
1998 - 2000	Director, The University of Minnesota Gynecologic Oncology Fellow's Symposium
2003 - 2004	Research Director, Gynecologic Oncology Associates

Major Committee Assignments
National
1999 - 2000	Fellows Task Force Committee, Society of Gynecologic Oncologists
2001 - 2002	SGO Candidate Task force, Board member
2002	Board of Directors, National Ovarian Cancer Coalition
2002	GCF Communications Committee
2003 - 2004	SGO Program Committee (2004)
2003 - 2004	SGO Express Postgraduate Course Chairman (2004)
2004	SGO Candidate Task force, Board member
2004 - 2005	SGO Branding committee, Candidate representative
2005 - 2007	SGO Marketing/Communications Committee

Regional
2000 - 2002	Executive Board, Massachusetts Society of Clinical Oncologists Chair, Communications Committee
2001 - 2002	Alza Pharmaceuticals - Northeast Advisory Board
2003	Chairman of Medical Advisory board, National Ovarian Cancer Coalition, San Diego Chapter

Hospital
1996 - 1997	Resident Selection Committee, Department of Obstetrics and Gynecology, UCLA Medical Center
1999 - 2000	Resident Promotion's Committee, Department of Obstetrics, Gynecology, and Women's Affairs, University of Minnesota School of Medicine
2000 - 2002	Quality Assurance Committee, Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center
2000 - 2002	Marketing Committee, Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center
2001 - 2002	PPS Billing Committee, Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center
2003	Sharp Mary Birch Operating Room Steering Committee
2006	Palomar Operating Room Steering Committee

Professional Societies
1992	American Medical Association Member
1993	American College of Obstetricians and Gynecologists Fellow
1997	Daniel Morton Society Member
1997	American Association of Gynecologic Laparoscopists Member
1999	American Association of Cancer Research Member
2000 - 2002	New England Association of Gynecologic Laparoscopists Member
2000	2000 – 2002 Massachusetts Society of Clinical Oncologists Member
2000	Society of Gynecologic Oncologists Candidate
2000	American Society of Clinical Oncology Member
2001 - 2002	New England Association of Gynecologic Oncologists Candidate
2001 - 2002	New England Obstetrics & Gynecology Society Member Japanese Society of Gynecologic Oncology Member

Editorial Boards
1996	Ad hoc reviewer Obstetrics Gynecology
2000	Ad hoc reviewer Journal of Clinical Oncology
2000	Ad hoc reviewer Fertility and Sterility
2000	Ad hoc reviewer Gynecologic Oncology
2000 - 2006	Editor-in-Chief Women’s Oncology Review

Awards
1984 - 1987	Founder's Day Scholastic Achievement, Indiana University
1987	Mortar Board Member
1997	Outstanding Resident in Gynecologic Endoscopy, Department of Obstetrics and Gynecology, UCLA Medical Center
1998	Amgen Pharmaceuticals Educational Award
1998	Rhone-Poulenc Clinical Research Award
1999	Pfizer Pharmaceutical Award - "Best Fellow Research Paper", Department of Obstetrics, Gynecology, and Women's health, University of Minnesota
2003	International Association of Culinary Professionals - "Health and Special Diet Category" ~ Cookbook of the Year (2003)

COURSES OR LABORATORIES

1986-1987	Indiana University Department of Mathematics Graduate Assistant, Lecturer Undergraduate Calculus Students (MAI19)
1997 - 2000	University of Minnesota Medical School Third-year Clerkship in Obstetrics & Gynecology "Introduction to pap smear screening" Lecturer University of Minnesota Medical School
1997 - 2000	University of Minnesota Medical School Third-year Clerkship in Obstetrics & Gynecology "Gynecologic Cancer Screening" Lecturer University of Minnesota Medical School
1997 - 2000	Preceptor/lecturer ofresidents on Gynecologic Oncology Service, Department of Obstetrics, Gynecology, and Women's Health. University of Minnesota Medical Center,
2000 - 2002	Beth Israel Deaconess Obstetrics/Gynecology Resident Lecture series Topics: Endometrial hyperplasia, Cervical cancer, Laparoscopic complications
2001 - 2002	Harvard Medical School Beth Israel Deaconess Medical Center Department of Obstetrics & Gynecology Course Director "Advanced laparoscopy for residents"
2002	"Gynecologist for the Non-Gynecologist" Harvard Medical School Postgraduate Course Co-Director January 16-19 Boston, MA
2003	Director of Gynecologic Oncology Critical Care Postgraduate Course at SGO (2004), San Diego, CA

LECTURES [Local, National, and International]

1997	Daniel Morton Research Day, Department of Obstetrics & Gynecology, U.C.L.A Medical Center, Utilization of the "See and Treat" technique for High Risk Pap Smears in Honduras. Los Angeles, CA
1998	Annual Fellow's Research Day, Division of Gynecologic Oncology, University of Minnesota, Extreme Drug Resistance (EDR) Testing in Ovarian Carcinoma. Minneapolis, MN
1998	Laparoscopic Complications. Department of Obstetrics & Gynecology, Autumn Seminar, University of Minnesota, Minneapolis, MN
1999	Annual Fellow's Research Day, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota The role of noscapine, a novel anti-tumor agent, in the treatment of ovarian and cervical carcinoma. Minneapolis, MN
1999	Annual Fellow's Research Day, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota The role of whole abdominal radiotherapy in advanced endometrial cancer. Minneapolis, MN
2000	Minimal invasive surgery for gynecologic malignancies. Gynecologic Laparoscopy and Urogynecology in the New Millennium. Mount Auburn Department of Obstetrics/Gynecology Postgraduate Course, Cambridge, MA
2000	Gynecologic Oncology Tumor Board, Advances in the Management of Gynecologic Cancers, Gynecologic Medical Oncology Program, Beth Israel Deaconess Medical Center, Boston, MA
2000	Laparoscopic Lymphadenectomy, New England Association of Gynecologic Laparoscopists, Fall Meeting, Boston, MA
2000	The role of adjuvant radiotherapy in adenocarcinoma of the endometrium. Radiotherapy Seminar, Indiana University Medical Center, Indianapolis, IN
2000	Minimal invasive surgery for gynecologic malignancies. Beth Israel Deaconess Medical Center, Grand Rounds, Department of Obstetrics & Gynecology, Boston, MA
2001	North American Bengali Conference Cancer Prevention in Women, Boston, MA
2001	Chemoresistance assays: Pros & Cons Medical Oncology Nurse/Gynecologic Nurse Oncologists meeting Sponsored by GlaxoSmithKline, Denver, CO
2001	"What's new in Women's Cancer" Surgical Issues in Gynecologic Cancers, Waltham, MA
2001	Current Approach to Management of Ovarian Cancer. Beth Israel Deaconess Medical Center, Grand Rounds, Department of Obstetrics & Gynecology, Boston, MA.
2001	New England Region Wound, Ostomy, and Continence Nurses Society Urinary Continent Conduits, Lowell, MA
2002	Ovarian Cancer and Nutrition, Ovarian Cancer Support Group Annual Meeting,University of Kansas Medical Center, Kansas City, MO
2002	The New Bethesda Classification Department of Pathology, University of Connecticut, Hartford, CT
2002	Update on Ovarian Cancer Keynote Invited Speaker Japanese Society of Gynecologic Oncology, Khyshu, Japan
2003	Ovarian Cancer and Nutrition Sharp Health Care 'Women's Day',San Diego, CA
2003	Ovarian Cancer and Nutrition, Book Club Dana Farber Cancer Center, Boston, MA
2003	New Technologies in Pap Smear Screening, Sponsored by Cytyc, Honolulu, HI
2003	New Technologies in Pap Smear Screening, Sponsored by Cytyc, Hilo,HI
2003	Challenges in the Management of Ovarian Cancer: Platinum and Paclitaxel Resistance Chicago, IL
2003	New Technologies in Pap Smear Screening, Sponsored by Cytyc, Tacoma, W A
2003	New Technologies in Pap Smear Screening, Grand Rounds, Department of Obstetrics& Gynecology, Scripps La Jolla Hospital, San Diego, CA
2003	Ovarian Cancer and Nutrition, Grand Rounds, Scripps La Jolla Hospital, San Diego, CA
2003	Managing the Side Effects of Chemotherapy, Town Forum, The Leukemia and Lymphoma Society, Sponsored by Amgen, San Diego, CA
2004	Management of Recurrent Ovarian Cancer, Sponsored by Glaxo Smithkline, Denver, CO

DESCRIPTION OF MAJOR CURRICULUM OFFERINGS

1997 - 2000	Director of the University of Minnesota FeIlowship Symposium. An ongoing course developed for gynecologic oncology fellows and oncology nurses, to continue educational goals in small informal settings throughout the year (6 courses/yr)
2001 - 2002	Director of Gynecology clerkship - 4th year Medical students. A course developed to introduce the basic outpatient and intraoperative management of gynecologic problems including pelvic floor dysfunction, urogynecology, and gynecologic oncology.
2001 - 2002	Director of OB/GYN residency mentorship program. A program designed to pair-up residents and clinical faculty, in order to create relationships and offer support to residents through the perils of residency.

PART III: BIBLIOGRAPHY

Original Articles

-	Moore D.H., Ghosh K., and Sutton G. Spontaneous occurrence of gangrene due to Clostridium septicum in a patient with advanced endometrial carcinoma, Infectious Diseases in Obstetrics and Gynecology 2: 34 - 37 (1994)
-	Ghosh K., Moore D.H., and Sutton G. Epithelial ovarian cancer complicating renal transplantation, American J. Obstetrics and Gynecology 171(1): 276 -277 (1994)
-	Kim Y.B., Holschneider C.H., Ghosh K., Neiberg R.K., and Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: report of seven cases and review ofliterature, Cancer 79 (2): 320 - 327 (1997)
-	Ghosh K., Segura A., Crispen C., Montz FJ. Use of the "See and Treat" technique for the management of high risk abnormal pap smears in a Third-World Country. Int J Gynecol Cancer, 7, 144-50 (1997)
-	Holsclmeider C.H., Cristoforoni P.M., Ghosh K., Punyasavatsut M., Abed E., Montz FJ. Endogenous versus Exogenous IL-IO in Postoperative Intraperitoneal Adhesion Formation in a Murine Model. J Surg Research, 70,138-143 (1997)
-	Buyalos R.P.,Ghosh, K., and Daneshmand S.T. Infertile Women of Advanced Reproductive Age: Variability of Day 3 FSH and E, Levels, J Reprod Med, Vol 43, No 12, 1023-1026 (1998)
-	Ghosh K., Morris 1., Marcella del Carmen and Montz F.J. Epidemiological characteristics of non-compliant patients with cervical dysplasia in underserved Areas. J of Lower Gen Tract Dis, Vol 3, No.3, 171-175 (1999)
-	Holschneider C.H., Ghosh K., and Montz F.J. "See and Treat" in the management of high grade squainous intra-epithelial lesions ofthe cervix: A resource utilization analysis employing "activity based cost" accounting techniques. Obstet Gynecol, Vol 94, No.3, 377-185 (1999)
-	Ghosh K., Dusenbury K.E. and Twiggs L.B. Cardiac Metastasis of Cloaca genic Carcinoma of the Vagina: A Case and Review of Gynecologic Malignancies with Cardiac Metastasis. Gynecol Oncol, 76(2), 208-212 (2000)
-	Ghosh K., Geller M.A., and Twiggs L.B. Erosion of an Intraperitoneal Chemotherapy Catheter Resulting in an Enterovaginal Fistula. Gynecol Oncol, 77(2),327-329 (2000)
-	Ghosh K., Dorigo 0, Bristow R., and Berek J.S. Radical surgical management of Leiomyomatous Peritonealis Disseminata. J Am Coil Surg, 191(2),212-215 (2000)
-	Ghosh K., Murray K.P., Padilla L.A.,Downs L.S. Jr.,Carson L.F., and Dusenbury K.E.. Using the Belly Board Device to Reduce the Small Bowel Volume within Pelvic Radiation Fields in Women with Early Cervical Carcinoma. Gynecol Oncol, 83, 271-275 (2001)
-	Ghosh K., Downs L.S., Padilla-Paz 1., Twiggs L.B., and Carson L.F. The Implementation of Critical Pathways and the Cost Reduction in Gynecologic Oncology. Gynecol Oncol, 83, 378-382 (2001)
-	Downs LS, Ghosh K, Dusenbery KE, Cosin JA. Stage IV carcinoma of the Bartholin gland managed with primary chemoradiation. Gynecol Oncol, 87(2):210-2 (2002)
-	Montz FJ., Osias J., Gardner G., Bovicelli A., Hakakha B.A, and Ghosh K. Significance of "Normal" Endometrial Cells in Cervical Cytology from Asymptomatic Postmenopausal Women Receiving Hormone Replacement Therapy. (Manuscript in Press - Gynecologic Oncology)
-	Downs L.S. Jr., Ghosh K., Padilla-Paz 1., Carson L.F., Twiggs L.B., and Cosin J.A. Burch Colposuspension at the time of Radical Hysterectomy. (Manuscript in Press - Gynecologic Oncology)

PROCEEDINGS OF MEETINGS

-	Ghosh K., Cristoforoni P., Segura A., Crispen C., and Montz FJ. Use of the "See and Treat" technique for the management of abnormal pap smears in a third world country. Proc Western Assoc of Gynecol Oncol, 1995
-	Kim YB., Holschneider C.H., Ghosh K., Neiberg R.K., Heaps J.M., Leuchter R.S., and Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: report of seven cases and review of literature. Proc Western Assoc of Gynecol Oncol, 1996
-	Montz.FJ., Hesford J., Ghosh K. "See and Treat" in the management of high grade cervical intra-epithelial neoplasia: A resource utilization analysis employing activity based cost accounting techniques. Proc Western Assoc of Gynecol Oncol, 1996, Proc Soc Gynccol Oncol, 1997
-	Ghosh K., Holschneider C.H., Montz FJ. Inteleukin-10 dose response relation in the prevention of postoperative adhesions in a murine model. Proc Soc Gynecol Invest, 1997
-	Ghosh K., Daneslunand S., Buyalos R.P. Intercycle Variability of Basal Follicle- Stimulating Hormone (FSH) and Estradiol (E2) in Infertile Women of Advanced Reproductive Age. Proc Pac Coast Fer! Soc, 1997
-	Yamada S.D., Casey C., Chen L.,Leuchter R., Lagasse 1., Ghosh K., Berek J., Montz FJ. and Karlan B.Y. Radical vs. Modified Radical Hysterectomy for Treatment of Early Stage Cervical Cancer. Proc Western Assoc of Gynecol OncoL 1997
-	Ghosh K., Morris 1., and Montz FJ. Epidemiological Characteristics of nderserved Non-compliant Patients with Cervical Dysplasia. Proc Western Assoc of Gynecol Oncol, 1997
-	Ghosh K., Hakakha B., and Montz FJ. The Significance of Endometrial Cells on Pap Smears in Asymptomatic Postmenopausal Patients on Hormone Replacement Therapy. Proc Western Assoc of Gynecol Oncol, 1997
-	Dusenbery KE., Ghosh K., Vander Kooy MJ., Unger lA., Anderson lK, and Chen M.D. The University of Minnesota Experience with Postoperative Radiation Therapy (RT) for Uterine Sarcomas: Outcome, Patterns of Failure and Complications. Proc Am Radium Soc, 1998
-	Ghosh K., Schad T., Carson L.F., Twiggs L.B., Chen M.D., and Dusenbury K.E. A Comparison of Neoadjuvant Treatment Modalities for Locally Advanced Vulvar Cancer: Radiation Therapy versus Combination Chemotherapy and Radiation Therapy. Proc Am Radium Soc, 1998
-	Ghosh K. and Dusenbury K.E. Using the Belly Board Device to Reduce the Small Bowel Volume within Pelvic Radiation Fields in Women with Early Cervical Carcinoma. Proc Am Radium Soc, 1998
-	Ghosh K., Murray K.P., Chen M.D., Twiggs L.B.; and Carson L.F. The Use of the Extreme Drug Resistance (EDR) Assays in Refractory Patients With Ovarian Carcinoma. Proc Western Assoc of Gynecol Oncol, 1998
-	Ghosh K., Murray KP., Chen M.D., Twiggs L.B., Glubka B., Mitchell S., Schad T., and Carson L.F. The Rohi of Extreme Drug Resistance (EDR) Assays on Chemotherapeutic Choice and Response in Ovarian Carcinoma Patients undergoing Secondary Cytoreductive Surgery. Proc Western Assoc of Gynecol Oncol, 1998
-	Mitchell S.K., Twiggs L.B., Chen M.D., Glubka B., Ghosh K., and Carson L.F. A retrospective analysis of refractory ovarian cancer patients treated with Doxil (Liposomal Doxorubicin) Proc Soc Clin Res Assoc, 1998
-	Holschneider C.H., Ghosh K., and Montz F.J. "See and Treat" in the management of high grade squamous intra-epithelial lesions ofthe cervix: A resource utilization analysis employing "activity based cost" accounting techniques. Presented at the Nat GynecorOncol Fellows' Forum, 1999
-	Ghosh K., Wild R., Carson L.F., Twiggs L.B., and Ramakrishnan S. The role of noscapine, a novel anti-tumor agent, in the treatment of ovarian and cervical carcinoma Presented at the Nat Gynecol Oncol Fellows' Forum, 1999
-	Ghosh K., Wild R.C., Carson L.F., Twiggs L.B., and Ramakrishnan S. Noscapine: a new anti-tumor agent in the treatment of ovarian carcinoma Proc Am Assoc Cancer Res, 1999
-	Ghosh K., Padilla-Paz 1., Twiggs L.B., and Carson L.F. The Implementation of Critical Pathways in Gynecologic Oncology at a Tertiary Institution. Proc Western Assoc ofGynecol Oncol, 1999
-	Murray K.A, Walsh J.W., Stillman A.E., Ghosh K., Padilla-Paz 1., Cosin lA., Chen M.D., Johnson P.R., Fowler J.M., Carson L.F, Twiggs L.B.. A Prospective Blind Comparison of Spiral Computed Tomography (SCT) and Magnetic Resonance Imaging (MRI) in retreatment Evaluation of Cervical Carcinoma: A Pilot Study. Proc Western Assoc of Gynecol Oncol, Proc Soc Gynecol Oncol, 2000
-	Downs 1. Jr., Ghosh K., Padilla-Paz L., Carson L.F., Twiggs L.B., and Cosin lA. Burch Colposuspension at the Time of Radical Hysterectomy. Proc Soc Gynecol Surg, 2000
-	Ghebre, R, Ghosh K., Padilla-Paz 1., Downs L.S., Cosin J.A.,Carson L.F., Dusenbury K.E., Twiggs L.B.,and M. Dwight Chen. A Prospective Study of Radiotherapy with Concomitant Cisplatin and Pac1itaxel in High-Risk Cervical Cancer. Proc Western Assoc of Gynecol Oncol, 2000
-	Ghosh K., Uyar D., Downs L.S., Padilla L.A., Carson L.F.,Unger D., Dusenbery K.E. The role of whole abdominal radiation therapy in the management of advanced endometrial cancer. Proc Am Soc Ther Radiol Oncol., 2000
-	Berkenblit A., Lin E., Hickey C., Catamero D., Tung N., Kim Y., Ghosh K., Niloff J., and Cannistra S.A. Phase I Study of Docetaxel, Carboplatin, And Gemcitabine(DOCAGEM) as First-Line Therapy for Patients with High-Risk Epithelial Tumors of Mullerian Origin. Proc American Society of Clinical Oncology, 2001

REVIEWS, CHAPTERS AND EDITORIALS

-	Kim Y.B., Ghosh K., Ainbinder S., Berek J.S. Diagnostic and Therapeutic Advances in Gynecologic Oncology: Screening for Gynecologic Cancer, Gynecologic Oncology, Ozols, Robert F. (ed), Kluwer Academic Publishers, Boston, MA, 253-276, 1998
-	Ghosh K., K. Belani., and M. Dwight Chen. Gynecological Malignancies and Anesthesia, The Cancer patient, Anesthesia Clinics of North America, Ed. D. Edward Supkis, Jr, WB Saunders Co., Philadelphia, PA, Vol. 16, No.3, pp 629- 644, 1998
-	Ghosh K. and Carson L.C. Radiation induced recto-vaginal fistulas- indications for surgery and options, Seminars in Colon and Rectal Surgery, Vol. 10, No.l,p 26-35, March, 1999
-	Ghosh K. and Montz FJ. Postoperative care: Major Benign and Radical Surgery, Operative Gynecology. 2nd Edition, Editors: Gershenson D., DeCherney A., Curry S., Brubaker 1. W.B. Saunders, Chapter 10, p 89-122, 2001
-	Ghosh K. Invasive Vaginal Cancer, Colposcopy: A Practical Approach, Editors: Twiggs L.B., Prendiville W., Tatti S.A., and Ritter J. (Manuscript in Press)
-	Ghosh K. and Niloff JM. Vaginal Bleeding an/or Pelvic Mass, Clinical Practice of ematology and Oncology: Presentation, Diagnosis, and Treatment. Chapter editor: Atkins M. (Manuscript in Press)
-	Ghosh K. and DeCherney A.H. 'The Empty Cradle' Book Review

BOOKS, MONOGRAPHS AND TEXTBOOKS

Ghosh K. ,Carson L.F. and Cohen,E , Betty Crockers' Living with Cancer.
McMillian Publishing

CLINICAL COMMUNICATIONS

-	Schink J.C, Ghosh K., and Glubka B. Taxol, Carboplatin and Hexalen (TAXCHEX) in Ovarian Cancer, Clinical Developments in Women's Cancer, Vol 8, No.2, 1-4 (1998)
-	Ghosh K. and DeCherney A.H. Long-Term use of Depo-Provera in a 27-Year- Old Patient with Family History of Myocardial Infarction, International Correpondence Society of Obstetricians & Gynecologists - Collected Letters 37 (12): 2-3 (1996)

Escondido Ob-Gyn Medical Group, Inc - 488 E.Valley Pkwy - Escondido, CA 92025 - Tel: 760-233-1896

Website developed by Medical Website Experts